BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 22454488)

  • 61. [Update on voriconazole].
    Dtsch Med Wochenschr; 2003 Aug; 128(33):1738. PubMed ID: 12968630
    [No Abstract]   [Full Text] [Related]  

  • 62. Voriconazole treatment for less-common, emerging, or refractory fungal infections.
    Perfect JR; Marr KA; Walsh TJ; Greenberg RN; DuPont B; de la Torre-Cisneros J; Just-Nübling G; Schlamm HT; Lutsar I; Espinel-Ingroff A; Johnson E
    Clin Infect Dis; 2003 May; 36(9):1122-31. PubMed ID: 12715306
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Editorial commentary: Antifungal therapeutic drug monitoring progress: getting it right the first time.
    Andes D; Lepak A
    Clin Infect Dis; 2012 Aug; 55(3):391-3. PubMed ID: 22610924
    [No Abstract]   [Full Text] [Related]  

  • 64. [Voriconazole-associated phototoxicity].
    Serra Soler G; Delgado Sánchez O; Esteban Marcos E; Martínez-López I; Femenías Sureda M
    Farm Hosp; 2006; 30(6):386-7. PubMed ID: 17298198
    [No Abstract]   [Full Text] [Related]  

  • 65. Voriconazole.
    Med Lett Drugs Ther; 2002 Jul; 44(1135):63-5. PubMed ID: 12138377
    [No Abstract]   [Full Text] [Related]  

  • 66. Trichosporon surgical wound infection in a renal allograft recipient successfully treated with voriconazole.
    Sundaram M; Anandbabu K; Basu G; Devasia A; Tamilarasi V
    Transplantation; 2010 Sep; 90(5):588-9. PubMed ID: 20814301
    [No Abstract]   [Full Text] [Related]  

  • 67. Voriconazole-associated myositis.
    Shanmugam VK; Matsumoto C; Pien E; Rosen J; Kumar P; Whelton S; Steen V
    J Clin Rheumatol; 2009 Oct; 15(7):350-3. PubMed ID: 20009971
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Successsful voriconazole treatment of disseminated fusarium infection in an immunocompromised patient.
    Consigny S; Dhedin N; Datry A; Choquet S; Leblond V; Chosidow O
    Clin Infect Dis; 2003 Jul; 37(2):311-3. PubMed ID: 12856225
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Utilisation, efficacy and safety of voriconazole: prospective, non-interventional study on treatment of IFIs in clinical practice.
    Heinz WJ; Silling G; Böhme A
    Curr Med Res Opin; 2011 Feb; 27(2):335-42. PubMed ID: 21155707
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Treating disseminated fusariosis: amphotericin B, voriconazole or both?
    Ho DY; Lee JD; Rosso F; Montoya JG
    Mycoses; 2007 May; 50(3):227-31. PubMed ID: 17472622
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Candida krusei arthritis in a patient with hematologic malignancy: successful treatment with voriconazole.
    Sili U; Yilmaz M; Ferhanoglu B; Mert A
    Clin Infect Dis; 2007 Oct; 45(7):897-8. PubMed ID: 17806057
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Voriconazole-induced QT interval prolongation and ventricular tachycardia: a non-concentration-dependent adverse effect.
    Alkan Y; Haefeli WE; Burhenne J; Stein J; Yaniv I; Shalit I
    Clin Infect Dis; 2004 Sep; 39(6):e49-52. PubMed ID: 15472801
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Severe hyponatraemia during invasive pulmonary aspergillosis treatment with voriconazole in a octogenarian patient with chronic obstructive pulmonary disease].
    Qanneta R; Pi I Sanchez J; Martí Triguero N; Moltó Llarena E
    Rev Esp Geriatr Gerontol; 2013; 48(5):249-50. PubMed ID: 23706911
    [No Abstract]   [Full Text] [Related]  

  • 74. Voriconazole for fungal corneal ulcers.
    Parchand S; Gupta A; Ram J; Gupta N; Chakrabarty A
    Ophthalmology; 2012 May; 119(5):1083. PubMed ID: 22551602
    [No Abstract]   [Full Text] [Related]  

  • 75. Differences in voriconazole trough plasma concentrations per oral dosages between children younger and older than 3 years of age.
    Shima H; Miharu M; Osumi T; Takahashi T; Shimada H
    Pediatr Blood Cancer; 2010 Jul; 54(7):1050-2. PubMed ID: 20146339
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Successful voriconazole therapy of disseminated Fusarium solani in the brain of a neutropenic cancer patient.
    Vincent AL; Cabrero JE; Greene JN; Sandin RL
    Cancer Control; 2003; 10(5):414-9. PubMed ID: 14581897
    [No Abstract]   [Full Text] [Related]  

  • 77. Fusarium sepsis, voriconazole, and the skin.
    Elston DM
    Cutis; 2010 Apr; 85(4):176-7. PubMed ID: 20486453
    [No Abstract]   [Full Text] [Related]  

  • 78. Evaluation of hepatotoxicity with off-label oral-treatment doses of voriconazole for invasive fungal infections.
    Gorski E; Esterly JS; Postelnick M; Trifilio S; Fotis M; Scheetz MH
    Antimicrob Agents Chemother; 2011 Jan; 55(1):184-9. PubMed ID: 20974867
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Voriconazole photosensitivity: 7 cases].
    Auffret N; Janssen F; Chevalier P; Guillemain R; Amrein C; Le Beller C
    Ann Dermatol Venereol; 2006 Apr; 133(4):330-2. PubMed ID: 16733446
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [Present and future of voriconazole in the treatment of invasive mycoses: the inseparable binomial diagnosis-treatment].
    Quindós G; Del Palacio A; Pontón J
    Rev Iberoam Micol; 2007 Sep; 24(3):179-80. PubMed ID: 17874853
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.